Femasys (FEMY) announced the appointment of Kelley Nicholas as Chief Commercial Officer, CCO. Nicholas will be responsible for leading the execution and optimization of Femasys’ commercial strategy to drive revenue growth across its entire portfolio, with a particular focus on expanding the U.S. infertility market and building key international partners. Prior to joining Femasys, Nicholas served as Head of Sales at NeuroPace (NPCE)
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FEMY:
- Femasys: Strategic Partnerships and Revenue Growth Drive Buy Rating with $12 Price Target
- Femasys announces partnership with Carolinas Fertility Institute
- Femasys Announces Public Offering and Private Placement
- Femasys prices 3.6M shares at 85c in underwritten public offering
- Femasys announces common stock offering, no amount given